AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARROW, INC. Director's Dealing 2009

Oct 16, 2009

31774_dirs_2009-10-15_1dddfc2c-4ee7-4028-a42e-ec266c29c4fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2009-10-14

Reporting Person: Schupp Joachim PH (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-10-14	Employee Stock Option (Right to Buy)	$1.7	A	215000	Acquired	2019-10-14	Common Stock (215000)	Direct

Footnotes

F1: The shares underlying the option vest 1/12th per quarter commencing on the first full quarter after the initial grant date of October 14, 2009.